Seeking Alpha


Send Message
View as an RSS Feed
View edgargi's Comments BY TICKER:
Latest comments  |  Highest rated
  • Arena Faces Slim Chances Of Approval For Weight Drug [View article]
    (I worked 20 years with the pharmaceutical Co. Roche, Sanofy, Winthrop, Specia Rhonne Poulenc as Product manager, and 15 as consulttant)

    Nancy: Arena has a great future and has more products in the pipeline a phase III a another in phase I.
    If Arena emphasizes that only the high dose group has significant consequence is true. The balance risk- benefits is taken by the Dr. no for the patient. 5% of body weight lost is excellent. The worst scenario is that FDA ask for a larger sample.
    Edgar Giraldo
    Mar 2, 2012. 09:59 AM | Likes Like |Link to Comment
  • RXI's Orphan Drug & Fast Track Index (27 Stocks) => Rx [View instapost]
    I`ve just discovered you page. B.Sc; 40 years worked for the pharma industry in the marketing side.(Roche, Aventis, Whintrop, Specia Rhone Poulanc & independant consultant) I invested in DNDN BVTI with great results. Thanks
    Jan 28, 2012. 12:05 PM | Likes Like |Link to Comment